Clinical Trials Directory

Trials / Unknown

UnknownNCT04772599

Measurement of Noradrenaline Concentrations Using Different Dilution Methods

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Norepinephrine is the vasopressor of choice for the treatment of peri-anesthetic arterial hypotension. The use of this drug at significantly lower concentrations (dilution factor between 40 and 200) than the commercial preparation is increasingly common in the operating room ("baby-noradrenaline"). In addition, dilution errors are potentially serious for the patient (hypertensive peak) The preparation of precise dilutions is an important factor for the safe use of this medically In this study, the investigators wish to compare the dilution method of the protocol with another method of preparation (left to the free choice of the participant).

Conditions

Timeline

Start date
2021-02-21
Primary completion
2021-07-01
Completion
2021-07-01
First posted
2021-02-26
Last updated
2021-02-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04772599. Inclusion in this directory is not an endorsement.